# FDA Inspection 1079838 - Carter BloodCare at Keller - January 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-keller/75ebccbb-c2cf-4134-a1e1-c78ab2b78056
Source feed: FDA_Inspections

> FDA Inspection 1079838 for Carter BloodCare at Keller on January 24, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079838
- Company Name: Carter BloodCare at Keller
- Inspection Date: 2019-01-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1242651 - 2024-06-26](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-keller/96df6fce-f9f2-4f2e-a401-28d9243b0228)
- [FDA Inspection 1015107 - 2017-06-13](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-keller/c4449a58-533f-4f18-82c6-4cdeba2d8644)
- [FDA Inspection 910813 - 2015-01-21](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-keller/b10cc6ec-3125-44d5-b114-615d131aabc8)
- [FDA Inspection 835678 - 2013-06-11](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-keller/b7973f44-391f-43b2-8080-b639c30ece16)
- [FDA Inspection 721800 - 2011-04-27](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-at-keller/1bd75e1e-966d-4554-8d68-049659fe10df)

Company: https://www.keypedia.com/companies/carter-bloodcare-at-keller/8f19929c-5e7a-4107-b230-14fbc0c51c83

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d